William Blair Upgrades 10x Genomics to Outperform

Benzinga Newsdesk www.benzinga.com Positive 94.5%

Neg 0% Neu 0% Pos 94.5%

William Blair analyst Matt Larew upgrades 10x Genomics (NASDAQ:TXG) from Market Perform to Outperform.

Comments

No comments yet. Be the first!